AAD Raises $11 Million For Mastitis R&D

AAD’s first on-farm product will focus on improving milk production and quality by controlling mastitis.

Follow Veterinary Practice News on Twitter at @vetpetnews.

Advanced Animal Diagnostics (AAD) reported in March that it closed an $11 million Series B round of equity financing. The investment represents the largest single investment in research and development to diagnose mastitis, the costliest disease for dairy producers worldwide, according to the Durham, N.C.-based company.

The financing was led by Intersouth Partners and included Novartis Venture Funds as well as other private investors.

AAD’s first on-farm product will focus on improving milk production and quality by controlling mastitis. Future products will monitor disease states, reproductive, nutritional and overall health status of production animals, according to the company.

“With this investment, AAD will be able to bring to market a new generation of diagnostics technologies that will revolutionize the way farmers approach animal health, allowing them to detect and diagnose diseases in their animals more quickly and efficiently than ever before,” said Joy Parr Drach, president and CEO of AAD.

AAD it expects the financing to support hiring for key positions, production and manufacturing and on-farm economic trials of its first product line. The firm is seeking cooperators for those on-farm trials.

Want more Veterinary Practice News? Go here.

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.